Baricitinib in Idiopathic Granulomatous Mastitis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Baricitinib
Related studies linked through entity extraction aliases.
Inflammation and Depression in People With HIV
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Baricitinib in Neuromyelitis Optica Spectrum Disorders
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Baricitinib Plus Glucocorticoid for Eosinophilia in IgG4-RD
- Status
- UNKNOWN
- Phase
- NA
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
- Status
- RECRUITING
- Phase
- PHASE3
Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT)
- Status
- COMPLETED
- Phase
- PHASE2
Baricitinib for Steroid-resistant/Relapse Immune Thrombocytopenia
- Status
- UNKNOWN
- Phase
- PHASE2
Baricitinib for Cutaneous Dermatomyositis
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Combination of Inhaled DNase, Baricitinib and Tocilizumab in Severe COVID-19
- Status
- UNKNOWN
- Phase
- NA
Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease
- Status
- COMPLETED
- Phase
- PHASE2
Neurodegenerative Alzheimer's Disease and Amyotrophic Lateral Sclerosis (NADALS) Basket Trial
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Tocilizumab Versus Baricitinib in Patients With Severe COVID-19
- Status
- COMPLETED
- Phase
- NA
COVID-19 VaccinE Response in Rheumatology Patients
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Baricitinib (LY3009104) in Children With COVID-19
- Status
- TERMINATED
- Phase
- PHASE3
Efficacy and Safety of Baricitinib in Patients With Moderate and Severe COVID-19
- Status
- UNKNOWN
- Phase
- PHASE3
Efficacy and Safety of Baricitinib in Sjogren's Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
ConsideRAte Study - Splenic Stimulation for RA
- Status
- RECRUITING
- Phase
- NA
Baricitinib in Patients With Relapsing or naïve Dermatomyositis
- Status
- RECRUITING
- Phase
- PHASE3
Baricitinib in Hospitalized Covid-19 Patients With Diabetes Mellitus
- Status
- WITHDRAWN
- Phase
- PHASE3